A friend of mine has been living well with lung cancer for five years -- working, running several miles a day, traveling, doing good stuff with his family, and generally enjoying the pleasures of everyday life. He knows the cancer will eventually kill him, but has been making the most of every remaining minute. Then, a month ago, things suddenly turned dramatically south. Severe shortness of breath, constant coughing, sleeplessness, fatigue, ...

Read more...

Top stories in health and medicine, October 6, 2014From MedPage Today:

  1. Dallas Ebola Case a Distraction. Lost in all the brouhaha about the Dallas Ebola case is one salient fact: Thomas Eric Duncan, now reportedly in serious condition in Texas Health Presbyterian Hospital, didn't catch the virus in the U.S. He caught it some 5,700 miles away in Liberia.
  2. RA ...

    Read more...

We’re born into our bodies, and we take that for granted. Our first job is to take a breath, something we’ll hopefully do many millions of times and never think about.  That first breath changes everything: Our blood starts to flow through our heart and lungs in a different way and for the first time we taste a new world. Before we’re born, all our needs are met via an artery and ...

Read more...

Top stories in health and medicine, October 1, 2014From MedPage Today:

  1. Targeted Drugs Build on Efficacy Record in Melanoma. Targeted therapy solidified and clarified its role in the treatment of advanced melanoma, as studies showed superiority over chemotherapy, and that two targeted drugs outperform one.
  2. Fish Oil Flops Again in Afib Study. High-dose fish oil failed to reduce atrial fibrillation ...

    Read more...

Top stories in health and medicine, September 30, 2014From MedPage Today:

  1. Data Confirm Anti-ALK Activity in Rare NSCLC. Objective responses occurred in 72% of patients with mutation-specific non-small cell lung cancer (NSCLC) treated with crizotinib (Xalkori).
  2. Case Reports: PET Imaging in Dementia. In two cases of progressing dementia, PET imaging with amyloid and tau tracers helped to clarify the diagnosis ...

    Read more...

Top stories in health and medicine, September 29, 2014From MedPage Today:

  1. Plans Wrestling With Narrow Networks, Accurate Doc Lists. Narrow provider lists are only one of several network adequacy issues that insurers and regulators are grappling with.
  2. Ebola: 'Magic Bullets' or Current Tools? European health authorities want to compile an overview of all the available data on experimental medications for ...

    Read more...

Estrogen therapy and breast cancer: The pharmacist said no It’s not often that I find myself speechless. I have heard all sorts of stories in my office -- as a sexuality counselor, I am often humbled by the trust that people place in me and how much they disclose about their private lives. But one conversation I had with a patient literally made my jaw drop. The patient is a ...

Read more...

Up to this point, it had only been a hypothesis: That celebrity firepower can definitively drive consumer health behavior in a certain direction. The case here concerns whether women wish to embark on a genetic hunting expedition to see if they are at high risk of developing a particular disease such as breast cancer, and the motivator in this case is Angelina Jolie. The actress underwent genetic testing for mutations related ...

Read more...

Top stories in health and medicine, September 26, 2014From MedPage Today:

  1. Study: Minor Memory Problems Merit Attention. Patients who reported having lost a step mentally were at nearly triple the risk of being diagnosed with definite cognitive impairment later on, albeit with a lag of about 6 to 10 years.
  2. Chlamydia Still Common: CDC. Chlamydia continues to be the most ...

    Read more...

Top stories in health and medicine, September 23, 2014From MedPage Today:

  1. One Insurer Holds Obamacare Fate in Two States. Here's a health law pop quiz: Which two states have the least successful Obamacare health insurance exchanges?
  2. RT Regimens Preserve QOL in Prostate Ca. Almost 90% of men with localized prostate cancer remained sexually active 5 years after treatment with blood ...

    Read more...

Most Popular